Pluripotent Stem Cell Single-Cell Passage and Differentiation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing human embryonic stem cells are challenging due to the need for complex conditions, risk of viral and immunogenic contamination from xenogeneic cells, and loss of pluripotency and genetic stability when passing cells as single cells.

Innovation Solution

The method involves culturing pluripotent stem cells as clusters, releasing them as single cells using enzymes like TrypLE™ Express, and plating them on a tissue culture substrate such as MATRIGEL™, allowing expansion and subsequent differentiation without loss of pluripotency or gain of chromosomal abnormalities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If xenogeneic cells are used in culture systems, then cell proliferation and maintenance of stem cells is achieved, but risk of viral and immunogenic contamination increases

Engineering Contradiction:
Improvecell proliferationVSAvoidviral and immunogenic contamination
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent removes feeder cells from the culture system entirely, extracting the harmful component that causes contamination while maintaining stem cell proliferation through feeder-free culture conditions and defined media formulations

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces defined media components and growth factors as intermediaries to replace the function of feeder cells, enabling stem cell maintenance without direct contact with animal-derived cells that could introduce viruses or immunogenic proteins

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If stem cells are passed as single cells, then ease of handling and quantification is improved, but loss of pluripotency and genetic stability occurs

Engineering Contradiction:
Improveease of handlingVSAvoidpluripotency and genetic stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The patent changes the physical and chemical parameters of the culture environment, including media composition, oxygen levels, and substrate properties, to maintain pluripotency and genetic stability even when cells are handled as single cells

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements preventive measures beforehand by using defined media with specific growth factors and antioxidants, and by optimizing culture conditions to prevent stress-induced differentiation and chromosomal abnormalities before they occur during single-cell passage

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

3Stability of the object's composition

If complex culture conditions are used, then maintenance of pluripotency is achieved, but device complexity and manufacturing difficulty increase

Engineering Contradiction:
Improvepluripotency maintenanceVSAvoidculture system complexity
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent replaces complex, expensive feeder cell systems with disposable, defined media formulations that can be easily manufactured and stored, simplifying the overall system while maintaining pluripotency

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent defines specific media parameters and culture conditions that can be standardized and scaled, transforming complex biological systems into controllable parameter-based protocols suitable for industrial manufacturing

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the maintenance, passage, and differentiation of pluripotent stem cells as single cells with preserved pluripotency and genetic stability, facilitating large-scale culturing and reducing the risk of contamination.

Implementation Method 1

releasing them as single cells using enzymes like TrypLE™ Express

Methodology Applied
Scientific EffectEnzymatic digestion: Enzyme

Data Source

PatentUS10316293B2Methods for producing single pluripotent stem cells and differentiation thereof
Publication Date: 2019.06.11 JANSSEN BIOTECH INC
  • US10316293B2 patent drawing
  • US10316293B2 patent drawing
  • US10316293B2 patent drawing

AI summary

The present invention relates to the field of pluripotent stem cell culture and methods facilitate pluripotent stem cell culture at industrial levels.